Business Description
Imunon Inc
NAICS : 325412
SIC : 2834
ISIN : US15117N6022
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.67 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 39.6 | |||||
3-Year EPS without NRI Growth Rate | 36.6 | |||||
3-Year FCF Growth Rate | 33.6 | |||||
3-Year Book Growth Rate | -40.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 2.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -51.3 | |||||
Shareholder Yield % | 4.65 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -89.56 | |||||
ROA % | -60.46 | |||||
ROIC % | -389.65 | |||||
ROC (Joel Greenblatt) % | -1089.55 | |||||
ROCE % | -84.36 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.89 | |||||
EV-to-EBIT | 0.1 | |||||
EV-to-EBITDA | 0.11 | |||||
EV-to-FCF | 0.11 | |||||
Price-to-Net-Current-Asset-Value | 1.23 | |||||
Price-to-Net-Cash | 1.67 | |||||
Earnings Yield (Greenblatt) % | 1000 | |||||
FCF Yield % | -163.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imunon Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.18 | ||
Beta | -0.53 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 16.65 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 16.65 - 16.65 | ||
Shares Outstanding (Mil) | 9.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imunon Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imunon Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Imunon Inc Frequently Asked Questions
What is Imunon Inc(LTS:0HUZ)'s stock price today?
When is next earnings date of Imunon Inc(LTS:0HUZ)?
Does Imunon Inc(LTS:0HUZ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |